JHSM

Journal of Health Sciences and Medicine (JHSM) is an unbiased, peer-reviewed, and open access international medical journal. The Journal publishes interesting clinical and experimental research conducted in all fields of medicine, interesting case reports, and clinical images, invited reviews, editorials, letters, comments, and related knowledge.

EndNote Style
Index
Original Article
Efficacy of serum lactate/albumin ratio as a prognostic biomarker in patients with ventilator-associated pneumonia
Aims: This study aims to evaluate the efficacy of the serum lactate/albumin ratio (LAR) as a prognostic marker in patients with ventilator-associated pneumonia (VAP) who are hospitalized in the intensive care unit (ICU).
Methods: This single-center retrospective observational clinical study was conducted between January 1, 2022, and October 1, 2024. The study group comprised 58 patients admitted to the ICUs of Malatya Training and Research Hospital, Turkiye, with intubation but without a diagnosis of pneumonia at the time of admission. These patients were diagnosed with VAP 48 hours after intubation. The serum LAR was calculated within the first 24 hours after admission to the ICU and correlated with mortality and morbidity.
Results: The mean age of the patients was 68 years, with the majority being over 65 years of age. Of the 58 patients included in the study, 43 (74.1%) ultimately succumbed to their illness. The LAR of those who died in the study was significantly higher than that of those who survived. The LAR was identified as a reliable predictor, exhibiting a sensitivity of 83.7% and a specificity of 60% when a cutoff value of 1.13 was applied. The survival time of patients with a LAR of ?1.13 was significantly longer than that of patients with a ratio of >1.13.
Conclusion: In our study, the mortality prediction performance of the LAR in patients with VAP was superior to that of the serum lactate level or serum albumin level alone. Therefore, the LAR may be a useful and readily available prognostic factor for early risk stratification of VAP patients.


1. Papazian L, Klompas M, Luyt, CE. Ventilator-associated pneumonia in adults: a narrative review. Int Care Med. 2020;46(5):888-906.
2. Fernando SM, Tran A, Cheng W, et al. Diagnosis of ventilator-associated pneumonia in critically ill adult patients-a systematic review and meta-analysis. Int Care Med. 2020;46(6):1170-1179.
3. Walaszek M, Kosiarska A, Gniadek A, et al. The risk factors for hospital-acquired pneumonia in the intensive care unit. Przegl Epidemiol. 2016; 70(1):107-110.
4. Kalil AC, Metersky ML, Klompas M, et. al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61-e111.
5. Augustyn B. Ventilator-associated pneumonia: risk factors and prevention. Crit Care Nurse. 2007;27(4):32-40.
6. Kendall H, Abreu E, Cheng AL. Serum albumin trend is a predictor of mortality in ICU patients with sepsis. Biol Res Nurs. 2019;21(3):237-244.
7. Akirov A, Masri-Iraqi H, Atamna A, Shimon I. Low albumin levels are associated with mortality risk in hospitalized patients. Am J Med. 2017; 130(12):1465.e11-1465.e19.
8. Aziz M, Fatima R, Lee-Smith W, Assaly R. The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis. Crit Care. 2020;26;24(1):255.
9. Suetrong B, Walley KR. Lactic acidosis in sepsis: it’s not all anaerobic: implications for diagnosis and management. Chest. 2016;149(1):252-261.
10. Gharipour A, Razavi R, Gharipour M, Mukasa D. Lactate/albumin ratio: an early prognostic marker in critically ill patients. Am J Emerg Med. 2020;38(10):2088-2095.
11. Shin J, Hwang SY, Jo IJ, et al. Prognostic value of the lactate/albumin ratio for predicting 28-day mortality in critically ILL sepsis patients. Shock. 2018;50(5):545-550.
12. Kong T, Chung SP, Lee HS, et al. The prognostic usefulness of the lactate/albumin ratio for predicting clinical outcomes in outof-hospital cardiac arrest: a prospective, multicenter observational study (koCARC) study. Shock. 2020;53(4):442-451.
13. Guo W, Zhao L, Zhao H, et al. The value of lactate/albumin ratio for predicting the clinical outcomes of critically ill patients with heart failure. Ann Transl Med. 2021;9(2):118.
14. Gök A, Kasapoğlu US, Acun Delen L, Özmen F, Banazili S. Lactate/albumin ratio as a prognostic factor for short-time mortality in critically ill patients with coronavirus disease-2019. Turk J Intensive Care. 2021;19(Suppl 1):62-72.
15. Magill SS, Klompas M, Balk R, et al. Developing a new, national approach to surveillance for ventilator-associated events. Am J Crit Care. 2013;22(6):469-473.
16. Ruchita K, Sourya A, Samarth S, et al. Serum lactate-albumin ratio: soothsayer for outcome in sepsis. Cureus. 2023;15(3):e36816.
17. Jia Liang Z, Hui L, Li W, et al. Association of lactate to albumin ratio and bicarbonate with short-term mortality risk in patients with acute myocardial infarction. BMC Cardiovascular Disorders. 2022;22(1):490.
18. Stijn B, Despoina K, George D, et al. Prevalence, risk factors, and mortality for ventilatorassociated pneumonia in middle-aged, old, and very old critically ill patients*. Crit Care Med. 2014;42(3):601-609.
19. Sen Z, Nan C, Liansheng M. Lactate-to-albumin ratio: a promising predictor of 28-day allcause mortality in critically Ill patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2024;33(6):107536.
20. Guo-Guo Z, Jia-Hui H, Qi Y, et al. Lactate-to-albumin ratio is associated with in-hospital mortality in patients with spontaneous subarachnoid hemorrhage and a nomogram model construction. Front Neurol. 2022; 17(13):1009253.
Volume 8, Issue 1, 2025
Page : 85-90
_Footer